Meta Health Limited (SGX:5DX) said it has used SG$882,000 of the SG$1.4 million raised from its renounceable non-underwritten rights issue, mainly for debt repayment and working capital, according to a Friday filing on the Singapore Exchange.
The healthcare technology firm allocated SG$790,000 for loan repayments, using SG$252,000 so far, including full repayment of a SG$150,000 loan from MWA Capital due March 2025.
Another SG$640,000 was set aside for corporate and working capital needs, of which SG$630,000 has been spent on employee expenses, legal fees, rental, and corporate costs.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。